|
Compounds Show Promise in Suppressing Fragile X Toxicity
Application
Compounds for the treatment of Fragile X-associated tremor/ataxia syndrome.
Key Benefits
11 known, FDA approved drugs identified that reduced rCGG-mediated lethality to a certain degree.
3 of these drugs also rescued locomotion deficits.
Technical Summary
Fragile X syndrome (FXS) is the most common inheritable form of cognitive...
Published: 9/18/2023
Contributor(s): Peng Jin, Abrar Qurashi
|